1. Abbott, S. R., Abu-Shumays, A., Loeffler, K. O., and Forrest, I. S. (1975). High pressure liquid chromatography of cannabinoids as their fluorescent dansyl derivatives. Res. Commun. Chem. Pathol. Pharmacol.10, 9–19.
2. Agurell, S., Gustafsson, B., Holmstedt, B., Leander, K., Lindgren, J.-E., Nilsson, I., Sandberg, F., and Asberg, M. (1973). Quantitation of Δ1-THC in plasma from cannabis smokers. J. Pharm. Pharmacol.25, 554–558.
3. Agurell, S., Binder, M., Fonseka, K., Lindgren, J.-E., Leander, K., Martin, B., Nilsson, I. M., Nordqvist, M., Ohlsson, A., and Widman, M. (1976a). Cannabinoids: Metabolites hydroxylated in the pentyl side-chain. In Nahas, G. G. (ed.), Marihuana: Chemistry, Biochemistry and Cellular Effects.Springer, New York, pp. 141–57.
4. Agurell, S., Levander, S., Binder, M., Bader-Bartfai, A., Gustafsson, B., Leander, K., Lindgren, J.-E., Ohlsson, A., and Tobisson, B. (1976b). Pharmacokinetics of Δ8-tetrahydrocannabinol in man after smoking: relations to physiological and psychological effects. In Braude, M. C., and Szara, S. (eds), Pharmacology of Marihuana.Raven, New York, 49–61.
5. Agurell, S., Lindgren, J.-E., and Ohlsson, A. (1979). Introduction to quantification of cannabinoids and their metabolites in biological fluids. In Nahas, G. G., and Paton, W. D. M. (eds), Marihuana: Biological Effects.Pergamon, Oxford, 3–13.